Yu, T.-C.; Chou, W.-C. Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma. J Med Cases 2026, 17 (5), 231-237. https://doi.org/10.14740/jmc5313.